2019
Qatar Pharma and Al Sulaiti v. Saudi Arabia
Qatar Pharma and Ahmed Bin Mohammad Al Haie Al Sulaiti v. Kingdom of Saudi Arabia
Saudi Arabia
Qatar
Investments in two locally incorporated companies in the pharmaceutical industry and three warehouses for products in Riyadh, Jeddah and Dammam.
Claims arising out of the alleged repudiation of long-term sales contracts concluded between Saudi Arabia’s Ministry of Health and the claimants, after Saudi Arabia suspended diplomatic relations with Qatar in 2017. According to the claimants, the Ministry’s measures included a failure to pay for products supplied by the claimants under these contracts and allegedly forced them to close their warehouses in the country.
Secondary: C - Manufacturing
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
Data not available
Data not available
Fernández-Armesto, J.
Poncet, C.
Ziadé, N.
None
Data not available
Data not available
Indirect expropriation
Fair and equitable treatment/Minimum standard of treatment, including denial of justice claims
Most-favoured nation treatment
Fair and equitable treatment/Minimum standard of treatment, including denial of justice claims
Most-favoured nation treatment
Pending
https://globalarbitrationreview.com/article/1189489/saudi-arabia-faces-another-claim-over-qatar-blockade (requires subscription)
https://www.iareporter.com/articles/saudi-arabia-faces-another-investor-arbitration-claim-under-organisation-for-islamic-cooperation-investment-treaty/ (requires subscription)
https://www.iareporter.com/articles/saudi-arabia-faces-another-investor-arbitration-claim-under-organisation-for-islamic-cooperation-investment-treaty/ (requires subscription)